Business Description
Palisade Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US6963892046
Description
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 33.69 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -12.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 78 | |||||
| 3-Year EPS without NRI Growth Rate | 78.8 | |||||
| 3-Year FCF Growth Rate | 72.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.42 | |||||
| 9-Day RSI | 51.35 | |||||
| 14-Day RSI | 46.5 | |||||
| 6-1 Month Momentum % | -33.31 | |||||
| 12-1 Month Momentum % | -76.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.15 | |||||
| Quick Ratio | 5.15 | |||||
| Cash Ratio | 4.81 | |||||
| Days Sales Outstanding | 365 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -298.9 | |||||
| Shareholder Yield % | -150.86 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -5138 | |||||
| Net Margin % | -4920 | |||||
| FCF Margin % | -4435.62 | |||||
| ROE % | -91.22 | |||||
| ROA % | -76.46 | |||||
| ROIC % | -759.25 | |||||
| ROC (Joel Greenblatt) % | -4735.93 | |||||
| ROCE % | -89.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.38 | |||||
| PB Ratio | 0.4 | |||||
| Price-to-Tangible-Book | 0.4 | |||||
| EV-to-EBIT | 0.45 | |||||
| EV-to-EBITDA | 0.45 | |||||
| EV-to-Revenue | -21.86 | |||||
| EV-to-Forward-Revenue | 0.76 | |||||
| EV-to-FCF | 0.53 | |||||
| Price-to-Net-Current-Asset-Value | 0.42 | |||||
| Price-to-Net-Cash | 0.46 | |||||
| Earnings Yield (Greenblatt) % | 223.65 | |||||
| FCF Yield % | -169.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Palisade Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.233 | ||
| EPS (TTM) (€) | -25.229 | ||
| Beta | 1.87 | ||
| Volatility % | 93.41 | ||
| 14-Day RSI | 46.5 | ||
| 14-Day ATR (€) | 0.036251 | ||
| 20-Day SMA (€) | 5.223 | ||
| 12-1 Month Momentum % | -76.04 | ||
| 52-Week Range (€) | 4.882499 - 32.024999 | ||
| Shares Outstanding (Mil) | 0.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Palisade Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Palisade Bio Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Palisade Bio Inc Frequently Asked Questions
What is Palisade Bio Inc(STU:7NS0)'s stock price today?
The current price of STU:7NS0 is €5.22. The 52 week high of STU:7NS0 is €32.02 and 52 week low is €4.88.
When is next earnings date of Palisade Bio Inc(STU:7NS0)?
The next earnings date of Palisade Bio Inc(STU:7NS0) is 2024-05-12 Est..
Does Palisade Bio Inc(STU:7NS0) pay dividends? If so, how much?
Palisade Bio Inc(STU:7NS0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers